Post Profile

How to Cut Drug Prices? California Can Set a Model With Prop. 61

Despite all the disgust with pharmaceutical price gouging and the public shaming of CEOs like Heather Bresch of EpiPen infamy and "pharma bro" Martin Shkreli, we've yet to see any concrete steps to actually cut drug prices. Now California voters can take matters, and their health, into their own hands - and set a national model by passing Proposition 61 in November. Writing for the industry website PharmExec.
read more


Related Posts

Mylan CEO now pushing a Big Pharma generic drug scheme that she once ripped as greedy

News : The Raw Story

Mylan Pharmaceuticals CEO Heather Bresch is still trying to contain the public relations damage her company is taking after it jacked up the price of EpiPens — but her latest gambit to save face opens her up to charges of hypocrisy ...

This pharma CEO is in the hot seat over EpiPen price hikes — and her dad is Sen. Joe Manchin

News : The Raw Story

Drug company CEO Heather Bresch affectionately describes the humble EpiPen as her “baby,” a once-middling product that she turned into a blockbuster. With aggressive advertising – and even more aggressive price hikes – Bresch has fo...

‘Pharma Bro’ backs down: Martin Shkreli will roll back outrageous Daraprim price gouge

News : The Raw Story

Turing Pharmaceuticals CEO Martin Shkreli said on Tuesday that he would not go through with his plan to raise the price of the anti-cancer drug Daraprim to $750 per pill, NBC News reported. “It is absolutely a reaction,” Shkreli sai...

WATCH: Mylan CEO Heather Bresch goes down in flames defending $16M pay raise and EpiPen price hike

News : The Raw Story

Mylan Pharmaceuticals CEO Heather Bresch is desperately trying to control the public relations disaster created by her company’s decision to jack up the price of the life-saving EpiPen drug by 450 percent over the past 12 years. In ...

No, EpiPen did not lower their drug price — they pulled a sneaky ’Pharma bro’ trick instead

News : The Raw Story

The maker of EpiPens announced Wednesday that it would cut out-of-pocket costs for the life-saving allergy treatment — but the drug’s actual cost won’t change. Mylan NV and its CEO, Heather Bresch, announced a discount program to he...


Copyright © 2016 Regator, LLC